Nifeviroc

934740-33-7

HIV Protease, CCR

GPCR/G Protein, Microbiology/Virology, Proteases/Proteasome, Immunology/Inflammation

0.9814

Nifeviroc (TD-0232) is an orally active CCR5 antagonist used in the study of HIV-1 infection.

O[C@@]1(C2=CC=CC=C2)[C@H](CN(C1)C(C3CCCC3)=O)CN4CCC(CC4)N(CC=C)C(OCC5=CC=C(C=C5)[N+]([O-])=O)=O

C33H42N4O6

590.71

Ice Packs

-20°C